Renal/Urology · PANCE / PANRE

Hypokalemia

Serum K <3.5 mEq/L; commonly from GI/renal losses; replace K and Mg.

Also known as: hypokalemia, low potassium

Overview

Serum potassium concentration <3.5 mEq/L. Severity: mild 3.0-3.4, moderate 2.5-2.9, severe <2.5. May reflect total body deficit (GI/renal loss, inadequate intake) or transcellular shift (alkalosis, insulin, beta-agonists).

Epidemiology

One of the most common electrolyte abnormalities in clinical practice. Affects ~20% of hospitalized patients. Strong association with diuretic use, hyperaldosteronism, GI losses, and certain endocrine and renal tubular disorders.

Try two board-style Hypokalemia questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1NeurologyMedium
A 24-year-old man is brought to the emergency department after waking unable to lift his arms or get out of bed. He had a long weightlifting session the previous evening followed by a large pasta dinner. Two briefer episodes of similar weakness occurred over the past year, each resolving within hours. He takes no medications and has had no vomiting or diarrhea. Vital signs are normal. Examination shows symmetric flaccid weakness of all four limbs, 2/5 proximally and 4/5 distally, with diminished deep tendon reflexes; sensation, facial strength, swallowing, and breathing are intact, and he is fully alert. Serum potassium is 2.0 mEq/L and creatinine is 0.9 mg/dL, and the ECG shows flattened T waves with prominent U waves. Which of the following is the most appropriate treatment of this attack?
  • AInfuse potassium chloride at 20 mEq/h until the serum potassium exceeds 4.0 mEq/L
  • BGive acetazolamide 250 mg by mouth now and repeat the same dose in six hours
  • CGive potassium chloride 0.5 mEq/kg by mouth and recheck the level in 30 minutes
  • DGive magnesium sulfate 2 g IV over one hour before giving any potassium
  • EInfuse potassium chloride 10 mEq in 500 mL of 5% dextrose in water over one hour
Reveal answer & full explanation
Correct answer: C — Give potassium chloride 0.5 mEq/kg by mouth and recheck the level in 30 minutes
  • AInfuse potassium chloride at 20 mEq/h until the serum potassium exceeds 4.0 mEq/L
  • BGive acetazolamide 250 mg by mouth now and repeat the same dose in six hours
  • CGive potassium chloride 0.5 mEq/kg by mouth and recheck the level in 30 minutes✓
  • DGive magnesium sulfate 2 g IV over one hour before giving any potassium
  • EInfuse potassium chloride 10 mEq in 500 mL of 5% dextrose in water over one hour

Why Give potassium chloride 0.5 mEq/kg by mouth and recheck the level in 30 minutes is correct

  • Abrupt, painless, symmetric flaccid quadriparesis on waking after strenuous exercise and a carbohydrate-rich meal, with hyporeflexia but intact sensation, bulbar function, respiration, and mentation, is an attack of hypokalemic periodic paralysis, a skeletal muscle channelopathy
  • Total body potassium is normal: insulin and beta-adrenergic tone drive potassium into muscle through Na-K-ATPase, so a serum value of 2.0 mEq/L here reflects a transcellular shift, not a deficit
  • Small oral increments restore sarcolemmal excitability while the shift reverses on its own: 0.5 to 1 mEq/kg by mouth, the serum potassium and the strength examination rechecked about every 30 minutes before any further dose, and rarely more than about 200 mEq in 24 hours
  • He swallows normally, so the oral route is available; were he unable to swallow, potassium chloride would be infused no faster than 10 mEq/h in 5% mannitol, the preferred vehicle because both dextrose and sodium chloride can deepen the weakness, with saline the fallback only when mannitol is unavailable
  • Continuous cardiac monitoring is mandatory whichever route is used, because the potassium can climb from 2.0 mEq/L to frankly hyperkalemic within a few hours as muscle releases the shifted potassium back into the serum

Why the others are wrong

  • Infuse potassium chloride at 20 mEq/h until the serum potassium exceeds 4.0 mEq/L - that endpoint, and the cumulative load needed to reach it, belong to a true depletion state; here the sequestered potassium returns to the extracellular space as the attack breaks, so driving the measured level above 4.0 mEq/L adds tens of milliequivalents the patient never lost and produces symptomatic rebound hyperkalemia (the trap is treating the number instead of the mechanism)
  • Infuse potassium chloride 10 mEq in 500 mL of 5% dextrose in water over one hour - the increment is reasonable but the vehicle is not: dextrose triggers insulin release, which drives still more potassium into muscle and deepens the paralysis, so potassium in periodic paralysis is given by mouth when the patient can swallow and otherwise in mannitol, never in a glucose-containing fluid (the trap is reaching for the default maintenance fluid)
  • Give acetazolamide 250 mg by mouth now and repeat the same dose in six hours - acetazolamide is maintenance prophylaxis that reduces how often attacks occur between episodes, it does not abort an attack already in progress, and it can worsen attacks in some SCN4A-related and thyrotoxic cases; it also leaves the profound hypokalemia and its ECG changes untreated right now (the trap is reaching for the disease-specific drug instead of the one that fixes the physiology at the bedside)
  • Give magnesium sulfate 2 g IV over one hour before giving any potassium - magnesium depletion keeps the kidney wasting potassium, so checking and correcting it is the right reflex when hypokalemia from true losses proves refractory, and even then it is given alongside potassium rather than in place of it; this attack is a transcellular shift with normal total body stores, nothing in his history suggests magnesium loss, and holding potassium for an hour leaves the paralysis and ECG changes untreated at a level of 2.0 mEq/L (the trap is applying the refractory-depletion rule to a shift)

Additional high-yield points

  • Contrast with diabetic ketoacidosis, where a large potassium load is correct: osmotic diuresis and insulin deficiency have depleted total body stores by 3 to 5 mEq/kg, so insulin is withheld until the potassium is above 3.3 mEq/L and 20 to 30 mEq of potassium is added to each liter of replacement fluid; there the potassium is gone from the body, whereas here it is only hiding inside cells, which is why the same order causes rebound hyperkalemia in this patient
  • Screen every adult presenting with a first attack for thyrotoxicosis with TSH and free T4; thyrotoxic periodic paralysis is most common in men of Asian or Latin American descent aged 20 to 40 and stops recurring once the patient is euthyroid
  • Once thyrotoxicosis is confirmed, nonselective beta blockade with propranolol is the adjunct that aborts attacks and blunts the rebound hyperkalemia by removing the adrenergic drive on Na-K-ATPase; it is not part of the acute treatment of primary familial hypokalemic periodic paralysis, so it follows the thyroid studies rather than preceding them
  • Attacks are provoked by carbohydrate loads, rest after strenuous exercise, alcohol, stress, and glucocorticoids; beta-agonists such as albuterol can precipitate one
  • Long-term management is trigger avoidance plus acetazolamide or dichlorphenamide, with a potassium-sparing diuretic as an alternative; dichlorphenamide is the only FDA-approved agent for primary periodic paralysis
  • Hyperkalemic periodic paralysis is the mirror image: shorter attacks provoked by fasting or potassium-rich foods, aborted with carbohydrate intake, inhaled albuterol, or IV calcium
Question 2RenalMedium
A patient has weakness and potassium of 2.6 mEq/L after several days of vomiting. Which of the following ECG findings is most expected?
  • AShortened QT interval with normal T waves
  • BOsborn J waves at the QRS-ST junction
  • CProminent U waves after the T wave
  • DPeaked T waves with QRS widening
  • ELong ST segment with normal T waves
Reveal answer & full explanation
Correct answer: C — Prominent U waves after the T wave
  • AShortened QT interval with normal T waves
  • BOsborn J waves at the QRS-ST junction
  • CProminent U waves after the T wave✓
  • DPeaked T waves with QRS widening
  • ELong ST segment with normal T waves

Why Prominent U waves after the T wave is correct

  • Hypokalemia delays ventricular repolarization, producing T-wave flattening, ST depression, and the characteristic prominent U waves following the T wave.
  • Several days of vomiting cause volume depletion that drives renal potassium wasting, matching the low potassium here.
  • Severe hypokalemia also warrants magnesium assessment because hypomagnesemia perpetuates the loss.

Why the others are wrong

  • Long ST segment with normal T waves — This is the hypocalcemia pattern, in which the QT prolongs through a longer ST segment while the T wave stays normal; a potassium of 2.6 mEq/L instead flattens the T wave and adds a U wave.
  • Peaked T waves with QRS widening — These are hyperkalemia changes, the opposite electrolyte disorder; choosing it ignores the measured potassium of 2.6 mEq/L.
  • Shortened QT interval with normal T waves — A short QT reflects hypercalcemia, not hypokalemia; hypokalemia actually prolongs repolarization, so this is the wrong direction.
  • Osborn J waves at the QRS-ST junction — this extra positive deflection at the J point, where the QRS meets the ST segment, is classically a sign of hypothermia; the extra wave of hypokalemia comes later, as a U wave after the T wave, together with T-wave flattening and ST depression (the trap is putting the extra wave in the wrong place).

That's 2. Get 7,700+ more.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Hypokalemia outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Diuretics: thiazide (HCTZ, chlorthalidone, indapamide), loop (furosemide, torsemide, bumetanide)
  • GI losses: vomiting, diarrhea, NG suction, laxative abuse
  • Renal: hyperaldosteronism (primary, secondary), Cushing syndrome, Liddle syndrome, Bartter/Gitelman syndromes, RTA types 1 and 2
  • Magnesium deficiency (renders K replacement ineffective)
  • Transcellular shift: alkalosis (each 0.1 pH rise lowers K ~0.4), insulin, beta-2 agonists (albuterol), refeeding syndrome, hypokalemic periodic paralysis
  • Decreased intake (rare alone): anorexia, alcoholism
  • Drugs: amphotericin B, aminoglycosides, cisplatin, high-dose penicillins

Pathophysiology

Total body potassium deficit develops from loss exceeding intake (GI, renal) or from intracellular shift. Hypokalemia hyperpolarizes excitable membranes, prolongs repolarization (QT prolongation, U waves), and increases risk of re-entrant arrhythmia. In skeletal muscle, severe hypokalemia causes weakness and rhabdomyolysis. Renal tubular damage from chronic hypokalemia can cause nephrogenic DI.

Clinical presentation

Symptoms

  • Mild: often asymptomatic
  • Moderate: weakness, fatigue, muscle cramps, constipation
  • Severe: flaccid paralysis (ascending), rhabdomyolysis, ileus, respiratory muscle weakness
  • Cardiac: palpitations, syncope from arrhythmia
  • Polyuria, polydipsia (nephrogenic DI from chronic hypokalemia)

Signs / physical exam

  • Hyporeflexia in severe hypokalemia
  • Hypotension (with concurrent volume depletion)
  • Hypertension if hyperaldosteronism etiology
  • Cardiac arrhythmias (premature beats, supraventricular and ventricular tachyarrhythmias, torsades de pointes if hypomagnesemia)
  • Ileus

Classic findings

ECG: T-wave flattening or inversion, prominent U waves, ST depression, prolonged QT, possible AV block; predisposes to torsades especially with hypomagnesemia.

Differential diagnosis

  • Diuretic-induced — Recent thiazide/loop initiation; urine K elevated; usually correctable with K replacement and oral supplementation
  • GI loss (vomiting/diarrhea) — Recent GI illness; metabolic alkalosis (vomiting) or acidosis (diarrhea); urine K low (<20) with diarrhea or laxatives; with active vomiting or NG suction most K loss is renal (bicarbonaturia plus secondary hyperaldosteronism), so urine K is often >20 but urine Cl is low (<20)
  • Primary hyperaldosteronism — Hypertension + hypokalemia + metabolic alkalosis; aldosterone/renin ratio >20 with elevated aldosterone
  • Bartter syndrome — Hereditary; hypokalemia + metabolic alkalosis + normal-low BP; loop-like; presents in childhood
  • Gitelman syndrome — Hereditary; hypokalemia + alkalosis + hypomagnesemia + hypocalciuria; thiazide-like; often diagnosed in adolescence/adulthood
  • RTA type 1 (distal) — Hypokalemia + non-gap metabolic acidosis + urine pH >5.5; kidney stones (calcium phosphate)
  • RTA type 2 (proximal) — Hypokalemia + non-gap acidosis + glycosuria/aminoaciduria (Fanconi syndrome)
  • Hypokalemic periodic paralysis — Episodic flaccid paralysis triggered by carbs/exercise; familial or thyrotoxic

Diagnostic workup

Diagnostic criteria

Serum K <3.5 mEq/L. Establish if renal vs extrarenal vs shift; assess concurrent acid-base, BP, and volume status to narrow differential.

Labs

  • BMP — serum K, BMP, magnesium (essential — Mg deficit causes refractory hypokalemia)
  • ABG or VBG for acid-base status
  • Urine K (spot or 24-h) and urine creatinine — TTKG or urine K:Cr ratio distinguishes renal from extrarenal loss
  • Urine K <20 mEq/L (spot) or <15 mEq/day (24-h) = extrarenal loss
  • Urine K >20 mEq/L or >25 mEq/day = renal loss
  • Plasma renin and aldosterone (aldo:renin ratio) if hypertension + hypokalemia
  • TSH if periodic paralysis suspected
  • Urine chloride (low in vomiting/contraction alkalosis; high in mineralocorticoid excess)

Imaging

  • Adrenal CT/MRI if primary hyperaldosteronism confirmed by labs

Diagnostic algorithm

Etiology CategoryUrine KAcid-BaseBPExample
Extrarenal lossLow (<20)Acidosis (diarrhea) or normalVariableDiarrhea, laxative abuse
Vomiting / NG suctionOften >20 while vomiting (renal loss); low after it stops; urine Cl <20Metabolic alkalosisOften lowBulimia, GI obstruction
DiureticHigh (>20)Metabolic alkalosisVariableThiazide, loop
Primary hyperaldosteronismHighMetabolic alkalosisHIGHConn adenoma
Bartter / GitelmanHighMetabolic alkalosisNormal/lowInherited tubular defect
RTA type 1 or 2HighNon-gap metabolic ACIDOSISNormalSjögren (RTA-1), Fanconi (RTA-2)
Transcellular shiftLow (no loss)Alkalosis or insulin effectVariableInsulin, beta-agonist, refeeding
Differential diagnosis of hypokalemia by urine K, acid-base status, and blood pressure.

Treatment

First-line

  • Replete potassium — oral if mild-moderate (K-Cl tablets 40-80 mEq/day in divided doses), IV if severe, symptomatic, NPO, or unable to tolerate oral
  • IV KCl: typically max 10 mEq/h peripheral (40 mEq/L), max 20 mEq/h central; cardiac monitor for rates >10 mEq/h
  • Each 10 mEq KCl raises serum K ~0.1 mEq/L (modest); large total body deficit (often >200-400 mEq) may exist with serum K of 3.0
  • REPLACE MAGNESIUM concurrently — hypomagnesemia causes K wasting and renders K supplementation ineffective. Goal Mg >2.0 mg/dL.
  • Address underlying cause: stop laxative, switch diuretic, treat hyperaldosteronism
  • K-sparing diuretic — spironolactone, eplerenone, amiloride, triamterene — when ongoing renal losses
  • Dietary K — bananas, oranges, potatoes, leafy greens, salt substitutes

Second-line / adjunct

  • Primary hyperaldosteronism: spironolactone or eplerenone; adrenalectomy for unilateral adenoma
  • Bartter/Gitelman: K and Mg replacement; spironolactone or amiloride; NSAIDs (Bartter only)
  • RTA: bicarbonate replacement with K supplementation
  • Thyrotoxic periodic paralysis: treat hyperthyroidism, beta-blocker (non-selective), K cautiously
  • Refeeding syndrome: gradual nutritional advancement, prophylactic phosphorus, K, Mg, thiamine
  • Recheck K every 2-6 hours during active replacement

Complications

  • Cardiac arrhythmias: PVCs, atrial and ventricular tachyarrhythmias, torsades de pointes
  • Sudden cardiac death (especially with concurrent QT-prolonging medications)
  • Muscle weakness, rhabdomyolysis
  • Respiratory failure (severe)
  • Ileus, constipation
  • Nephrogenic diabetes insipidus, polyuria
  • Hypertension if etiology is mineralocorticoid excess
  • Digoxin toxicity (hypokalemia potentiates) — important in patients on digoxin

PANCE pearls

  • ALWAYS check and replace magnesium when treating hypokalemia. Hypomagnesemia causes renal K wasting and makes K supplementation ineffective.
  • Rule of thumb: each 10 mEq KCl raises serum K only ~0.1 mEq/L. Patients with serum K 3.0 often have a total body deficit of 200-400 mEq.
  • Hypokalemia potentiates digoxin toxicity even at therapeutic levels — maintain K >4 in patients on digoxin.
  • ECG: T-wave flattening, U waves, ST depression, QT prolongation, predisposing to torsades.
  • Hypertension + hypokalemia + metabolic alkalosis = think primary hyperaldosteronism (Conn syndrome). Check ARR.
  • Gitelman syndrome: hypokalemia + alkalosis + low Mg + low urinary calcium. Bartter syndrome: similar but with normal/high urinary calcium and presents earlier.

References

  • KDIGO 2020 — KDIGO Controversies Conference on Potassium Management in Kidney Disease
  • Mount (Brenner & Rector 2020) — Disorders of Potassium Balance (Mount, in Brenner & Rector's The Kidney, 11th ed)

Practice Renal/Urology questions on FirstPassPA

Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.